SECTION 610.2 PROVIDES FDA WITH THE
AUTHORITY TO REQUEST THE SUBMISSIO OF PRODUCT LOT SAMPLES AND
RELEASE PROTOCOLS SHOWING THE IDENTITY OF THE LOT AND TEST RESULTS
OF ALL APPLICABLE TESTS FOR EACH LOT OF LICENSED BIOLOGICAL
PRODUCTS PRIOR TO THE DISTRIBUTION AND USE HUMANS. FDA REVIEWS THE
PROTOCOLS AND PERFORMS ITS OWN TESTING ON THE SAMPLES TO ASSURE
THAT A PARTICULAR LOT IS SAFE, PURE, POTENT, AND
EFFECTIVE.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.